Final Facilitator Guide - EngenderHealth

More documents

Recommendations

Info

Section 5h. Drug adherence is the most critical factor in treatment success.i. Poor adherence results in drug resistance and treatment failure.4. Differences with adults and issues with ART in children :a. Determining the dose of ART medicine is more complicated.b. Taste issues affect adherence in childrenc. Follow-up is dependent on care takersd. Adherence depends primarily on the caretaker.e. Nevirapine, as a single drug is given during delivery to prevent HIVtransmission to children. However this does not preventtransmission in all children. Among children who become infectedwith HIV in spite of Nevirapine there is likelihood that the virus intheir body will be resistant to Nevirapine. In such cases NevirapinebasedART regimens will not work.f. The family must be counseled and educated about ARV, includingthe need for adherence with follow-up medical visits and withmedications. Giving medication twice daily to a small child withoutever missing a dose is difficult and usually requires the participationof more than one caregiver. One caregiver may be at work or awaywhen a dose is due, and then the other caregiver must give thechild the medication. Usually several counseling sessions shouldbe provided to the family before medications are prescribed, sothat adherence is excellent from the first dose.g. All infants born to HIV positive mothers should be oncotrimoxazole starting at six weeks of age and until theyare proven to NOT have HIV which usually is confirmed at 18months of age. Cotrimoxazole prevents PCP-a kind of pneumonia(an opportunistic infections of the lungs).Facilitator’s Guide4Adherence to Treatment for HIV107
Section 64SECTION 6CARE AND SUPPORTSESSION 6.1 : HOME-BASED CAREObjectivesTrainer’s notesMethodology• To understand basic elements of home-based care and first aidfor PLHA.• To explore the role that family members can play inhome - based care.Facilitator’s Guide4Adherence to Treatment for HIV108Brainstorm, Discussing picture chartsRecommended TimeMaterialsSteps60 minutes• Flip chart• Markers• Tape• Participant’s manual Session 6.1—Handout ‘A’ : Preventive Home-Based Care• Participant’s manual Session 6.1—Handout ‘B’ : Managing Symptoms1. Begin the session by asking participants to try to answer thefollowing questions :• What is home-based care?• Why is home-based care effective and important?Refer to trainer’s resource ‘A’ for answers to these questions as
Page 1 and 2:
Adherence to Treatment for HIVA Tra
Page 3 and 4:
© 2006 EngenderHealth Society.F-6/
Page 5 and 6:
TABLE OF CONTENTSPREFACEACKNOWLEDGE
Page 7 and 8:
PREFACEWith funding from the Global
Page 9 and 10:
ACKNOWLEDGEMENTSWe acknowledge with
Page 11 and 12:
ABBREVIATIONSARTCD4GFATMIVDUMSMNNRT
Page 13 and 14:
The Facilitator Guide consists of:
Page 15 and 16:
How to use the facilitator guideThe
Page 17 and 18:
This symbol indicatesthe questions
Page 19 and 20:
8This box should becut and pasteona
Page 21:
This symbolindicates the triggerque
Page 24 and 25:
1SECTION 1Section 1INTRODUCTIONS AN
Page 26 and 27:
Page 28 and 29:
Section 1Then read out this definit
Page 30 and 31:
Page 32 and 33:
Section 1Summarize the results as f
Page 34 and 35:
Section 22. During the discussion,
Page 36 and 37:
Section 2Where does HIV come from?N
Page 38 and 39:
1SECTION 2Section 2HIV AND ANTIRETR
Page 40 and 41:
Section 210. You cannot contract HI
Page 42 and 43:
Section 2The list may include the f
Page 44 and 45:
Section 2• If you do not take you
Page 46 and 47:
Section 2Steps1. Ask the group if t
Page 48:
Section 26. Tell the group that to
Page 52 and 53:
2SECTION 3Section 3RESISTANCE AND A
Page 54 and 55:
Page 56 and 57:
Section 3most appropriate. Creativi
Page 58 and 59:
Section 34. Provide 15 minutes for
Page 60 and 61:
Section 3Case Study #2Devi, a perso
Page 62 and 63:
Page 64 and 65:
Section 37. Finish the session by r
Page 66 and 67:
Section 32. Ask for a volunteer to
Page 68 and 69: 2SECTION 4Section 4PREVENTION PRACT
Page 70 and 71: Section 4Reasons include• Parents
Page 72: Section 4Case Study #2Usha, A women
Page 76 and 77: 3SECTION 4Section 4POSITIVE PREVENT
Page 78 and 79: Section 45. After all four role pla
Page 80 and 81: Section 4Group ThreeReinfectionYou
Page 84 and 85: Section 4pouch is called the inner
Page 86 and 87: Section 4Choose four or five that y
Page 90 and 91: Section 4HIV status. Disclosing one
Page 92 and 93: Section 53. After, provide the foll
Page 94 and 95: Section 5Some examples could includ
Page 96 and 97: Section 57. Tell the group that we
Page 98 and 99: Section 5and have them draw or writ
Page 100 and 101: Section 5Characteristics of a Poor
Page 102 and 103: Section 52. Ask for six volunteers.
Page 104 and 105: 3SECTION 5Section 5COUNSELING ON AD
Page 106 and 107: Section 55. Begin a discussion with
Page 109 and 110: SCHEDULE FOR DAY 4Day Four : Care a
Page 111 and 112: Section 53. They should write their
Page 113 and 114: Section 54. Adherence to treatment
Page 115 and 116: Section 5III.Issues specific to men
Page 117: Section 54SECTION 5COUNSELING ON AD
Page 121 and 122: Section 64SECTION 6CARE AND SUPPORT
Page 123 and 124: Section 6(List these tasks on the f
Page 125 and 126: Section 73. Assign each group one o
Page 127 and 128: Section 73. Review Handout 7.2 : He
Page 129 and 130: Section 82. Participants will now d
Page 131 and 132: Section 84SECTION 8SERVICES FOR PLH
Page 137 and 138: Section 94SECTION 9SKILLS FOR PEER
Page 139 and 140: Section 97. After all groups are fi
Page 141 and 142: Section 9• A good relationship wi
Page 143 and 144: Section 9bottle with the label so t
Page 149 and 150: Section 10110CLOSINGSESSION 10.1 :
Page 151 and 152: Section 104 SECTION 10CLOSINGSESSIO
Page 153 and 154: Section 104 SECTION 10CLOSINGSESSIO
Page 155 and 156: Section 10As you go around the circ
Page 157 and 158: 12. Number of people living with HI
Page 159 and 160: 13. HIV cannot be transmitted by :
Page 161 and 162: 150Notes
show all

Final Facilitator Guide - EngenderHealth

Create successful ePaper yourself

Delete template?

Save as template?